Trinity Biotech (TRIB) EPS (Basic) Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -184.98% |
| Sep 30, 2024 | -23.86% |
| Jun 30, 2024 | -19.54% |
| Mar 31, 2024 | -21.23% |
| Dec 31, 2023 | -23.90% |
| Sep 30, 2023 | -29.50% |
| Jun 30, 2023 | -42.39% |
| Mar 31, 2023 | -26.75% |
| Dec 31, 2022 | -55.14% |
| Sep 30, 2022 | -33.64% |
| Jun 30, 2022 | -14.89% |
| Mar 31, 2022 | -43.92% |
| Dec 31, 2021 | 38.86% |
| Sep 30, 2021 | 59.87% |
| Jun 30, 2021 | -14.87% |
| Mar 31, 2021 | 45.38% |
| Dec 31, 2020 | 28.54% |
| Sep 30, 2020 | -3.71% |
| Jun 30, 2020 | -11.05% |
| Mar 31, 2020 | -8.07% |
| Dec 31, 2019 | 40.25% |
| Sep 30, 2019 | -11.61% |
| Jun 30, 2019 | 10.52% |
| Mar 31, 2019 | -10.87% |
| Dec 31, 2018 | 53.57% |
| Sep 30, 2018 | -16.25% |
| Jun 30, 2018 | -8.07% |
| Mar 31, 2018 | -8.53% |
| Dec 31, 2017 | 18.74% |
| Sep 30, 2017 | -14.01% |
| Jun 30, 2017 | -11.09% |
| Mar 31, 2017 | -14.26% |
| Dec 31, 2016 | -150.80% |
| Sep 30, 2016 | -15.29% |
| Jun 30, 2016 | -16.29% |
| Mar 31, 2016 | -16.86% |
| Sep 30, 2015 | 85.06% |
| Jun 30, 2015 | -43.18% |
| Mar 31, 2015 | 1.91% |
| Dec 31, 2014 | 4.37% |
| Sep 30, 2014 | 2.86% |
| Jun 30, 2014 | 1.74% |
| Mar 31, 2014 | 6.85% |